TUMOR MARKERS 2 Flashcards
Is one of the older oncofetal proteins still in use. It is not specific for the colon but is found in a variety of malignant and nonmalignant conditions such as breast, Gl, lung, ovary, pancreas, and prostate cancers.
Carcinoembryonic antigen (CEA)
It is elevated in alcoholism, inflammation of the bowel, cystic fibrosis, and in heavy cigarette smokers. Despite the nonspecificity of this, it is useful in establishing prognosis and in monitoring therapy. It is measured in body fluids other than serum (ascetic fluid, fluid from cyst, urine, or lavage from any cavity) may also aid in diagnosis.
Carcinoembryonic antigen (CEA)
Are glycoproteins defined by their antigenic property. They are cell surface antigens or secreted antigens that are expressed by tumor cells, and against which a monoclonal antibody or antibodies has been produced.
carbohydrate
Examples of mucin markers and blood group antigen markers.
Mucin markers
- CA15-3 and CA125
Blood Group Antigen
- CA19-9 and CA72-4
The use of ____ in cancer therapy has led to the development of a subset of patients who have human antimouse antibodies (HAMA), which interfere with mouse-derived monoclonal antibody immunoassays.
mouse monoclonal antibodies
The function of this is to cause liquefaction of seminal coagulum. 2Because of its tissue specificity, it became the first tumor marker recommended for screening for prostate cancer in older men.
Prostate-Specific Antigen (PSA)
Is a glycoprotein mucin present on mammary epithelium. Assays for this are not specific for breast cancer because they can be elevated in a variety of carcinomas. However, they are sensitive for breast cancer and are currently used to monitor patients following surgery.
CA15-3
Newer breast cancer markers
- CA549
- CA27.29
- breasr cancer mucin (BCM)
- mucin-like carcinoma-associated antigen (MCA)
Is a mucin-like oligosaccharide characterized by antibody first developed from mice immunized to a human colon cancer cell line (SW-1116). lt has a high specificity for pancreatic cancer but also recognizes other gastrointestinal cancers. It is also used clinically to monitor therapy and to predict disease recurrence. Because it is related to the Lewis substance, Lewis-negative patients will not produce this.
CA19-9
Is a glycoprotein defined by the monoclonal antibody OC125. It is a good marker for ovarian carcinomas.
CA125
Are marketed for use in the detection of all forms of GI cancer, but especially gastric cancer, which does not react especially well with other markers.
CA72-4
Is one of 14 subfractions of tumor-associated antigen (TA4). (Head, neck, lung, esophagus)
Squamous cell carcinoma antigen (SCC)
Is a marker for non-small cell lung cancer.
Cyfra 21-1
Is found in cell membranes of drug-resistant cells. It is theorized that it is active in transporting the drugs out of the cells. lt is normally found in kidney, liver, adrenal, and Gl tract cells. It can be measured using a monoclonal antibody, C219.
P-glycoprotein
Is the major iron storage protein and is found in most cells. It is frequently assayed as an indicator of iron status since the plasma or serum ferritin level is directly proportional to the body iron stores.
Ferritin
Is an antigen found on the surface of all nucleated cells. lt is a subunit of human leukocyte antigen (HLA) and is elevated in all diseases associated with rapid cell turnover. lt is used as a marker for leukemias, lymphoma, and multiple myeloma and it correlates well with B lymphocyte activity and elevated in HIV patients.
Beta2-Microglobulin
Is the connecting peptide between the A and B chain of proinsulin. lt is dissociated from these chains to produce active insulin. It is elevated in patients with increased endogenous insulin production, for example, insulinoma.
C-peptide
Is not elevated in patients receiving exogenous insulin.
C-peptide
Some patients with beta cell pancreatic tumors produce ____ levels of insulin but their C-peptide levels of insulin are uniformly ____.
fluctuating; high
Have been used as markers in multiple myeloma and in Waldenstrom’s macroglobulinemia
immunoglobulins